These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 7095120

  • 1. [Relation between pharmacodynamics and the pharmacokinetics of anti-arrhythmia agents].
    Gneushev ET, Starodubtsev AK, Kurapov AP, Kukes VG, Zisel'man SB.
    Farmakol Toksikol; 1982; 45(3):107-10. PubMed ID: 7095120
    [No Abstract] [Full Text] [Related]

  • 2. [Possibilities of clinical pharmacology in the evaluation of anti-arrhythmia and anti-angina drugs].
    Mazur NA, Metelitsa VI.
    Farmakol Toksikol; 1982; 45(3):59-63. PubMed ID: 7095129
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. How do pharmacokinetics relate to pharmacodynamics of antiarrhythmic drugs?
    Shanks RG.
    Eur Heart J; 1988 Feb; 9 Suppl B():51-6. PubMed ID: 3286268
    [No Abstract] [Full Text] [Related]

  • 6. [Determination of plasma concentrations of anti-arrhythmia agents].
    Flouvat B.
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():47-55. PubMed ID: 6803701
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical pharmacokinetics of the anti-arrhythmic agent changrolin].
    Chen WZ, Wang CG, Yang XY, Cai NS, Zhu JR.
    Yao Xue Xue Bao; 1985 Jul; 20(7):505-8. PubMed ID: 4096242
    [No Abstract] [Full Text] [Related]

  • 11. [Side effects of anti-arrhythmia drugs].
    Neugebauer A.
    Z Gesamte Inn Med; 1984 Jun 01; 39(11):249-52. PubMed ID: 6475169
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical pharmacology of old and new antiarrhythmic drugs.
    Nattel S, Zipes DP.
    Cardiovasc Clin; 1980 Jun 01; 11(1):221-48. PubMed ID: 7002302
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [General principles for choosing an anti-arrhythmia preparation and the treatment procedure in cardiac rhythm disturbances].
    Mazur NA.
    Klin Med (Mosk); 1982 May 01; 60(5):68-72. PubMed ID: 7109520
    [No Abstract] [Full Text] [Related]

  • 17. Classification and pharmacology of antiarrhythmic drugs.
    Kowey PR, Marinchak RA, Rials SJ, Bharucha DB.
    Am Heart J; 2000 Jul 01; 140(1):12-20. PubMed ID: 10874257
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The effects of propafenone in the treatment of ventricular arrhythmias with a malignant potential for resistance to conventional anti-arrhythmia medication].
    Câmpeanu A, Rădoi M, Serban-Pârâu G, Pleşca O, Nuţă M, Teodorescu V, Titirigă M.
    Med Interna; 1993 Jul 01; 45(1-2):35-41. PubMed ID: 8081689
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical pharmacology of anti-arrhythymia agents. II. Lignocaine, mexiletine, tocainide, phenytoin].
    Witkowska M.
    Kardiol Pol; 1981 Jul 01; 24(11-12):803-13. PubMed ID: 6804681
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.